| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT02962323 |
| P6099 | clinical trial phase | phase I clinical trial | Q5452194 |
| P582 | end time | 2009-12-01 | |
| P4135 | maximum age | 45 | |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 48 | |
| P4844 | research intervention | calcium oxalate | Q412399 |
| P580 | start time | 2009-11-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | An Open Label, Randomized, 2-Period, 2-Treatment,2-Sequence, Crossover, Single-Dose BE of Rosuvastatin Ca Tab 40 mg [Torrent,India] Versus Crestor 40 mg Tab [ AstraZeneca Pharmaceuticals LP, USA] in Healthy Subjects-Fed Condition. |